Skip to content
PragmaClin Logo

About us

PragmaClin Research Inc., established in 2020, is a Canadian health-tech innovator headquartered in St. John’s, Newfoundland and Labrador. Focused on transforming the assessment and management of Parkinson’s Disease (PD) and other neurological disorders, the company has developed PRIMS (Parkinson’s Remote Interactive Management System), a cutting-edge digital platform.

PRIMS is an advanced tool utilizing machine learning and 3D depth cameras to objectively assess motor symptoms of Parkinson’s Disease. This technology addresses the challenges of traditional, subjective, and infrequent PD evaluations by providing precise and consistent measurements. The system facilitates rural and in-clinic assessments, offering patients and clinicians improved access to timely and reliable data. PRIMS’ integration of the MDS-UPDRS international standard ensures compatibility with existing clinical practices while delivering enhanced insights for treatment planning.

Program engagement

Leadership

Bronwyn Bridges

CEO and Co-Founder

Status

Intellectual Property

Fundraising

Sector

Subsector

Our website uses cookies to ensure you get the best experience. Learn more about the policy

i.d.e.a. Fund Applications Open

Applications are now open for i.d.e.a. Fund Cohort 4

Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?

The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.

Applications are open from June 16 to July 7, 2025.